Taysha Gene Therapies, Inc. (TSHA)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $1.2M
- Jul 10 · Routine
- Form 4 sales
- 21
- On record
- Form 144 notices
- 32
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Jul 10, 2026Routine
Nagendran Sukumar, President and Head of R&D, sold 17.6% of their holdings
$1.2M200,000 shares at $6.24
- Jul 10, 2026Notice
Nagendran Sukumar, President and Head of R&D, filed a notice to sell 200,000 shares
$1.3M200,000 shares
- Apr 10, 2026Routine
Nagendran Sukumar, President and Head of R&D, sold 15% of their holdings
$892k200,000 shares at $4.46
- Apr 10, 2026Notice
Nagendran Sukumar, President and Head of R&D, filed a notice to sell 200,000 shares
$926k200,000 shares
- Feb 27, 2026Notice
Haque-Ahmed Rumana, Officer, filed a notice to sell 2,405 shares
$11k2,405 shares
- Feb 4, 2026No plan
Alam Kamran, CHIEF FINANCIAL OFFICER, sold 0.1% of their holdings
$7k1,655 shares at $4.52
- Feb 4, 2026Notice
McGinnis Emily, Affiliate-Chief Pat. Adv. & Ext. Aff. Off., filed a notice to sell 901 shares
$4k901 shares
- Feb 4, 2026Notice
Porter Fred, Affiliate-Chief of Staff & Tech.Op.Officer, filed a notice to sell 889 shares
$4k889 shares
- Feb 4, 2026Notice
McAuliffe Sean, Affiliate - Chief Business Officer, filed a notice to sell 914 shares
$4k914 shares
- Feb 4, 2026Notice
Haque-Ahmed Rumana, Officer, filed a notice to sell 697 shares
$3k697 shares
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jul 10, 2026 | TSHA | Nagendran Sukumar | President and Head of R&D | Sold | 200,000 | $6.24 | $1.2M | 936,410 | SEC |
| Jun 1, 2026 | Jun 2, 2026 | TSHA | Long Alison S | Director | AwardedStock Option (right to buy) | 42,671 | 42,671 | SEC | ||
| Jun 1, 2026 | Jun 2, 2026 | TSHA | Long Alison S | Director | Awarded | 21,335 | 127,178 | SEC | ||
| Jun 1, 2026 | Jun 2, 2026 | TSHA | Sepp-Lorenzino Laura | Director | AwardedStock Option (right to buy) | 42,671 | 42,671 | SEC | ||
| Jun 1, 2026 | Jun 2, 2026 | TSHA | Sepp-Lorenzino Laura | Director | Awarded | 21,335 | 127,178 | SEC | ||
| Jun 1, 2026 | Jun 2, 2026 | TSHA | Stalfort John A III | Director | AwardedStock Option (right to buy) | 42,671 | 42,671 | SEC | ||
| Jun 1, 2026 | Jun 2, 2026 | TSHA | Stalfort John A III | Director | Awarded | 21,335 | 1.2M | SEC | ||
| Jun 1, 2026 | Jun 2, 2026 | TSHA | Donenberg Phillip B. | Director | AwardedStock Option (right to buy) | 42,671 | 42,671 | SEC | ||
| Jun 1, 2026 | Jun 2, 2026 | TSHA | Donenberg Phillip B. | Director | Awarded | 21,335 | 241,289 | SEC | ||
| Apr 10, 2026 | Apr 13, 2026 | TSHA | Nagendran Sukumar | President and Head of R&D | Sold | 200,000 | $4.46 | $892k | 1.1M | SEC |
| Apr 10, 2026 | Apr 13, 2026 | TSHA | Nagendran Sukumar | President and Head of R&D | Exercised or settledEmployee Stock Option (right to buy) | 19,021 | 455,920 | SEC | ||
| Apr 10, 2026 | Apr 13, 2026 | TSHA | Nagendran Sukumar | President and Head of R&D | Exercised options | 19,021 | $1.71 | $33k | 1.3M | SEC |
| Feb 4, 2026 | Feb 6, 2026 | TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | Sold | 1,655 | $4.52 | $7k | 1.4M | SEC |
| Jan 26, 2026 | Jan 27, 2026 | TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | Sold | 102,817 | $4.72 | $485k | 1.4M | SEC |
| Jan 26, 2026 | Jan 27, 2026 | TSHA | Nagendran Sukumar | President and Head of R&D | Sold | 116,050 | $4.72 | $547k | 1.3M | SEC |
| Jan 26, 2026 | Jan 27, 2026 | TSHA | Nolan Sean P. | Chief Executive Officer | Sold | 178,101 | $4.72 | $840k | 2.9M | SEC |
| Jan 12, 2026 | Jan 14, 2026 | TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | AwardedEmployee Stock Option (right to buy) | 231,000 | 231,000 | SEC | ||
| Jan 12, 2026 | Jan 14, 2026 | TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | Awarded | 359,000 | 1.5M | SEC | ||
| Jan 12, 2026 | Jan 14, 2026 | TSHA | Nagendran Sukumar | President and Head of R&D | Sold | 200,000 | $4.71 | $942k | 1M | SEC |
| Jan 12, 2026 | Jan 14, 2026 | TSHA | Nagendran Sukumar | President and Head of R&D | Exercised or settledEmployee Stock Option (right to buy) | 200,000 | 474,941 | SEC | ||
| Jan 12, 2026 | Jan 14, 2026 | TSHA | Nagendran Sukumar | President and Head of R&D | Exercised options | 200,000 | $1.15 | $230k | 1.2M | SEC |
| Jan 12, 2026 | Jan 14, 2026 | TSHA | Nagendran Sukumar | President and Head of R&D | AwardedEmployee Stock Option (right to buy) | 274,000 | 274,000 | SEC | ||
| Jan 12, 2026 | Jan 14, 2026 | TSHA | Nagendran Sukumar | President and Head of R&D | Awarded | 427,000 | 1.4M | SEC | ||
| Jan 12, 2026 | Jan 14, 2026 | TSHA | Nolan Sean P. | Chief Executive Officer | AwardedEmployee Stock Option (right to buy) | 648,000 | 648,000 | SEC | ||
| Jan 12, 2026 | Jan 14, 2026 | TSHA | Nolan Sean P. | Chief Executive Officer | Awarded | 1M | 3.1M | SEC | ||
| Dec 1, 2025 | Dec 1, 2025 | TSHA | Nagendran Sukumar | President and Head of R&D | Sold | 370,172 | $4.58 | $1.7M | 1M | SEC |
| Dec 1, 2025 | Dec 1, 2025 | TSHA | Nagendran Sukumar | President and Head of R&D | Exercised or settledEmployee Stock Option (right to buy) | 370,172 | 563,617 | SEC | ||
| Dec 1, 2025 | Dec 1, 2025 | TSHA | Nagendran Sukumar | President and Head of R&D | Exercised options | 370,172 | $1.52 | $562k | 1.3M | SEC |
| Sep 10, 2025 | Sep 12, 2025 | TSHA | Nagendran Sukumar | President and Head of R&D | Sold | 200,000 | $3.23 | $646k | 1M | SEC |
| Sep 10, 2025 | Sep 12, 2025 | TSHA | Nagendran Sukumar | President and Head of R&D | Exercised or settledEmployee Stock Option (right to buy) | 41,150 | 292,855 | SEC | ||
| Sep 10, 2025 | Sep 12, 2025 | TSHA | Nagendran Sukumar | President and Head of R&D | Exercised options | 41,150 | $0.70 | $29k | 1.2M | SEC |
| Aug 21, 2025 | Aug 22, 2025 | TSHA | Nagendran Sukumar | President and Head of R&D | Sold | 57,054 | $2.85 | $163k | 1.2M | SEC |
| Aug 21, 2025 | Aug 22, 2025 | TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | Sold | 54,491 | $2.85 | $155k | 1.2M | SEC |
| Jun 2, 2025 | Jun 4, 2025 | TSHA | Stalfort John A III | Director | AwardedStock Option (right to buy) | 113,246 | 113,246 | SEC | ||
| Jun 2, 2025 | Jun 4, 2025 | TSHA | Stalfort John A III | Director | Awarded | 56,623 | 1.2M | SEC | ||
| Jun 2, 2025 | Jun 4, 2025 | TSHA | Donenberg Phillip B. | Director | AwardedStock Option (right to buy) | 113,246 | 113,246 | SEC | ||
| Jun 2, 2025 | Jun 4, 2025 | TSHA | Donenberg Phillip B. | Director | Awarded | 56,623 | 219,954 | SEC | ||
| Jun 2, 2025 | Jun 4, 2025 | TSHA | Long Alison S | Director | AwardedStock Option (right to buy) | 113,246 | 113,246 | SEC | ||
| Jun 2, 2025 | Jun 4, 2025 | TSHA | Long Alison S | Director | Awarded | 56,623 | 105,843 | SEC | ||
| Jun 2, 2025 | Jun 4, 2025 | TSHA | Sepp-Lorenzino Laura | Director | AwardedStock Option (right to buy) | 113,246 | 113,246 | SEC | ||
| Jun 2, 2025 | Jun 4, 2025 | TSHA | Sepp-Lorenzino Laura | Director | Awarded | 56,623 | 105,843 | SEC | ||
| May 30, 2025 | Jun 3, 2025 | TSHA | Manning Paul B | 10% owner | Bought | 750,000 | $2.75 | $2.1M | 2.8M | SEC |
| Mar 11, 2025 | Mar 13, 2025 | TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | Withheld for tax | 29,843 | $1.69 | $50k | 1.2M | SEC |
| Jan 2, 2025 | Jan 3, 2025 | TSHA | Nolan Sean P. | Chief Executive Officer | AwardedEmployee Stock Option (right to buy) | 892,500 | 892,500 | SEC | ||
| Jan 2, 2025 | Jan 3, 2025 | TSHA | Nolan Sean P. | Chief Executive Officer | Awarded | 892,500 | 2.1M | SEC | ||
| Jan 2, 2025 | Jan 3, 2025 | TSHA | Nagendran Sukumar | President and Head of R&D | AwardedEmployee Stock Option (right to buy) | 324,500 | 324,500 | SEC | ||
| Jan 2, 2025 | Jan 3, 2025 | TSHA | Nagendran Sukumar | President and Head of R&D | Awarded | 324,500 | 1.2M | SEC | ||
| Jan 2, 2025 | Jan 3, 2025 | TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | AwardedEmployee Stock Option (right to buy) | 431,000 | 431,000 | SEC | ||
| Jan 2, 2025 | Jan 3, 2025 | TSHA | Alam Kamran | CHIEF FINANCIAL OFFICER | Awarded | 431,000 | 1.3M | SEC | ||
| Jun 27, 2024 | Jul 1, 2024 | TSHA | Manning Paul B | 10% owner | Bought | 1.3M | $2.25 | $3M | 1.3M | SEC |
Sales, notices and lockups (53)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jul 10, 2026 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 4 sale | 200,000 | $1.2M | 17.6% | Routine | SEC |
| Jul 10, 2026 | Jul 10, 2026 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 144 notice | 200,000 | $1.3M | Notice | SEC | |
| Apr 10, 2026 | Apr 13, 2026 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 4 sale | 200,000 | $892k | 15.0% | Routine | SEC |
| Apr 10, 2026 | Apr 10, 2026 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 144 notice | 200,000 | $926k | Notice | SEC | |
| Feb 27, 2026 | Feb 27, 2026 | Haque-Ahmed Rumana | TSHA | Officer | Form 144 notice | 2,405 | $11k | Notice | SEC | |
| Feb 4, 2026 | Feb 6, 2026 | Alam Kamran | TSHA | CHIEF FINANCIAL OFFICER | Form 4 sale | 1,655 | $7k | 0.1% | No plan | SEC |
| Feb 4, 2026 | Feb 4, 2026 | McGinnis Emily | TSHA | Affiliate-Chief Pat. Adv. & Ext. Aff. Off. | Form 144 notice | 901 | $4k | Notice | SEC | |
| Feb 4, 2026 | Feb 4, 2026 | Porter Fred | TSHA | Affiliate-Chief of Staff & Tech.Op.Officer | Form 144 notice | 889 | $4k | Notice | SEC | |
| Feb 4, 2026 | Feb 4, 2026 | McAuliffe Sean | TSHA | Affiliate - Chief Business Officer | Form 144 notice | 914 | $4k | Notice | SEC | |
| Feb 4, 2026 | Feb 4, 2026 | Haque-Ahmed Rumana | TSHA | Officer | Form 144 notice | 697 | $3k | Notice | SEC | |
| Feb 4, 2026 | Feb 4, 2026 | Alam Kamran | TSHA | CHIEF FINANCIAL OFFICER | Form 144 notice | 1,655 | $8k | Notice | SEC | |
| Jan 26, 2026 | Jan 27, 2026 | Alam Kamran | TSHA | CHIEF FINANCIAL OFFICER | Form 4 sale | 102,817 | $485k | 6.6% | No plan | SEC |
| Jan 26, 2026 | Jan 27, 2026 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 4 sale | 116,050 | $547k | 8.1% | No plan | SEC |
| Jan 26, 2026 | Jan 27, 2026 | Nolan Sean P. | TSHA | Chief Executive Officer | Form 4 sale | 178,101 | $840k | 5.8% | No plan | SEC |
| Jan 23, 2026 | Jan 23, 2026 | Nolan Sean P. | TSHA | Chief Executive Officer | Form 144 notice | 168,078 | $856k | Notice | SEC | |
| Jan 23, 2026 | Jan 23, 2026 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 144 notice | 113,824 | $579k | Notice | SEC | |
| Jan 23, 2026 | Jan 23, 2026 | Haque-Ahmed Rumana | TSHA | Officer | Form 144 notice | 30,052 | $153k | Notice | SEC | |
| Jan 23, 2026 | Jan 23, 2026 | Porter Fred | TSHA | Affiliate-Chief of Staff & Tech.Op.Officer | Form 144 notice | 54,916 | $280k | Notice | SEC | |
| Jan 23, 2026 | Jan 23, 2026 | McGinnis Emily | TSHA | Affiliate-Chief Pat. Adv. & Ext. Aff. Off. | Form 144 notice | 32,077 | $163k | Notice | SEC | |
| Jan 23, 2026 | Jan 23, 2026 | McAuliffe Sean | TSHA | Affiliate - Chief Business Officer | Form 144 notice | 46,064 | $234k | Notice | SEC | |
| Jan 23, 2026 | Jan 23, 2026 | Alam Kamran | TSHA | CHIEF FINANCIAL OFFICER | Form 144 notice | 100,846 | $513k | Notice | SEC | |
| Jan 12, 2026 | Jan 14, 2026 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 4 sale | 200,000 | $942k | 16.6% | Routine | SEC |
| Jan 12, 2026 | Jan 12, 2026 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 144 notice | 200,000 | $996k | Notice | SEC | |
| Dec 1, 2025 | Dec 1, 2025 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 4 sale | 370,172 | $1.7M | 26.9% | Unusual | SEC |
| Nov 28, 2025 | Nov 28, 2025 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 144 notice | 370,172 | $1.8M | Notice | SEC | |
| Sep 22, 2025 | Sep 22, 2025 | Haque-Ahmed Rumana | TSHA | Officer | Form 144 notice | 10,770 | $30k | Notice | SEC | |
| Sep 10, 2025 | Sep 12, 2025 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 4 sale | 200,000 | $646k | 16.6% | Routine | SEC |
| Sep 10, 2025 | Sep 10, 2025 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 144 notice | 200,000 | $652k | Notice | SEC | |
| Aug 21, 2025 | Aug 22, 2025 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 4 sale | 57,054 | $163k | 4.7% | No plan | SEC |
| Aug 21, 2025 | Aug 22, 2025 | Alam Kamran | TSHA | CHIEF FINANCIAL OFFICER | Form 4 sale | 54,491 | $155k | 4.4% | No plan | SEC |
| Aug 21, 2025 | Aug 21, 2025 | Alam Kamran | TSHA | CHIEF FINANCIAL OFFICER | Form 144 notice | 54,491 | $156k | Notice | SEC | |
| Aug 21, 2025 | Aug 21, 2025 | McGinnis Emily | TSHA | Affiliate-Chief Pat. Adv. & Ext. Aff. Off. | Form 144 notice | 19,604 | $56k | Notice | SEC | |
| Aug 21, 2025 | Aug 21, 2025 | Nagendran Sukumar | TSHA | President and Head of R&D | Form 144 notice | 57,054 | $164k | Notice | SEC | |
| Aug 21, 2025 | Aug 21, 2025 | McAuliffe Sean | TSHA | Affiliate - Chief Business Officer | Form 144 notice | 27,590 | $79k | Notice | SEC | |
| Aug 21, 2025 | Aug 21, 2025 | Porter Fred | TSHA | Affiliate-Chief of Staff & Tech.Op.Officer | Form 144 notice | 50,451 | $145k | Notice | SEC | |
| Jul 5, 2024 | Jul 5, 2024 | McGinnis Emily | TSHA | Affiliate-Chief Pat. Advo. & Ext. Affairs Officer | Form 144 notice | 16,869 | $36k | Notice | SEC | |
| Jul 5, 2024 | Jul 5, 2024 | McAuliffe Sean | TSHA | Affiliate - Chief Business Officer | Form 144 notice | 25,505 | $55k | Notice | SEC | |
| Jul 5, 2024 | Jul 5, 2024 | Porter Fred | TSHA | Affiliate - Chief of Staff & Tech. Op. Officer | Form 144 notice | 33,335 | $72k | Notice | SEC | |
| Aug 24, 2023 | Aug 25, 2023 | Alam Kamran | TSHA | Chief Financial Officer | Form 4 sale | 33,000 | $77k | 11.3% | Routine | SEC |
| Aug 24, 2023 | Aug 24, 2023 | Alam Kamran | TSHA | CHIEF FINANCIAL OFFICER | Form 144 notice | 33,000 | $86k | Notice | SEC | |
| Jul 13, 2023 | Jul 14, 2023 | Session R.A. II | TSHA | 10% owner | Form 4 sale | 85,872 | $61k | 1.0% | No plan | SEC |
| Jun 23, 2023 | Jun 26, 2023 | Session R.A. II | TSHA | 10% owner | Form 4 sale | 28,608 | $20k | 0.3% | No plan | SEC |
| Jun 21, 2023 | Jun 22, 2023 | Session R.A. II | TSHA | 10% owner | Form 4 sale | 434,615 | $307k | 4.6% | No plan | SEC |
| Jun 20, 2023 | Jun 20, 2023 | Session R.A. II | TSHA | 10% owner | Form 144 notice | 1M | $700k | Notice | SEC | |
| Jun 1, 2023 | Jun 1, 2023 | McAuliffe Sean | TSHA | Affiliate - Chief Business Officer | Form 144 notice | 21,305 | $15k | Notice | SEC | |
| Jun 1, 2023 | Jun 1, 2023 | Porter Fred | TSHA | Affiliate - Chief Technical Officer | Form 144 notice | 42,491 | $30k | Notice | SEC | |
| May 11, 2023 | May 11, 2023 | McGinnis Emily | TSHA | Affiliate | Form 144 notice | 19,784 | $42k | Notice | SEC | |
| Aug 23, 2022 | Aug 24, 2022 | Alam Kamran | TSHA | Chief Financial Officer | Form 4 sale | 3,325 | $12k | 1.2% | Plan not stated | SEC |
| Aug 22, 2022 | Aug 22, 2022 | Alam Kamran | TSHA | Chief Financial Officer | Form 4 sale | 28,675 | $106k | 9.6% | Plan not stated | SEC |
| Jul 6, 2022 | Jul 7, 2022 | Prasad Suyash | TSHA | CMO and Head of R&D | Form 4 sale | 12,861 | $48k | 2.4% | Plan not stated | SEC |